Literature DB >> 16470581

Secondary pseudotumor cerebri in pediatric oncology and hematology: an unpredictable condition of varying etiology.

Felix Distelmaier1, Ulrich Göbel, Nicola Vandemeulebroecke, Ertan Mayatepek, Thorsten Rosenbaum, Hans-Jürgen Laws.   

Abstract

Secondary pseudotumor cerebri (PTC) in pediatric oncology and hematology is an unpredictable and under-recognized condition. It is characterized by increased cerebrospinal fluid (CSF) pressure of more than 25 cm H(2)O in the absence of underlying structural causes. Numerous conditions and medications have been implicated in the etiology of secondary PTC. Patients may suffer from incapacitating headaches and permanent visual loss, if they are not managed properly. We retrospectively analyzed the records of eight children, diagnosed with secondary PTC with an underlying hematological or oncological disease. Our study highlights the clinical features, contributing factors, and treatment options of this syndrome in children. 2007 Wiley-Liss, Inc

Entities:  

Mesh:

Year:  2007        PMID: 16470581     DOI: 10.1002/pbc.20783

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  3 in total

1.  An adolescent with suspected intracranial hypertension - ALL is not what it seems.

Authors:  Asgeir Store Jakola; Sasha Gulati
Journal:  Childs Nerv Syst       Date:  2012-01-28       Impact factor: 1.475

2.  Intracranial hypertension as the presenting symptom of duodenal cancer.

Authors:  Çağdaş Erdoğan; Eylem Değirmenci; Nedim Ongun; Levent Sinan Bir
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-03-14       Impact factor: 3.117

3.  Clinical spectrum of the pseudotumor cerebri complex in children.

Authors:  Daniel Tibussek; Dominik T Schneider; Nicola Vandemeulebroecke; Bernd Turowski; Martina Messing-Juenger; Peter H G M Willems; Ertan Mayatepek; Felix Distelmaier
Journal:  Childs Nerv Syst       Date:  2009-11-10       Impact factor: 1.475

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.